Moderna stock tumbled after the company issued a light 2025 sales outlook and cut its 2027 R&D budget. Is MRNA stock a sell?
We recently published a list of Must-See: Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other Jim Cramer’s best stocks for investors. In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy might lead […]
The latest trading day saw Moderna (MRNA) settling at $69.17, representing a +1.3% change from its previous close.